Request Free Sample
×
UK Allergy Immunotherapy Market
ID: MRFR/HC/54526-HCR
200 Pages
June 2025
UK Allergy Immunotherapy Market Research Report: By Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy, Oral Immunotherapy), By Product (Allergen Extracts, Conventional Immunotherapy, Biologics), By Indication (Allergic Rhinitis, Allergic Asthma, Atopic Dermatitis, Food Allergies) and By Patient Type (Pediatric, Adult, Geriatric) - Forecast to 2035
Industry Developments
Recent developments in the UK Allergy Immunotherapy Market have shown a notable increase in collaboration and innovation among key players, including Stallergenes Greer, Allergy Therapeutics, and Boehringer Ingelheim. In September 2023, Stallergenes Greer announced an initiative aimed at expanding their sublingual immunotherapy offerings to improve accessibility for patients with allergic rhinitis. Meanwhile, Allergy Therapeutics launched a new clinical trial for their grass pollen allergy treatment, reflecting the growing focus on research and development in the sector. The market also remains dynamic, with significant mergers and acquisition activities. In August 2023, Anergis completed a strategic acquisition of Allergenis aimed at enhancing their immunotherapy capabilities within the UK. The market is valued at approximately 183 million as of 2023, with a projected annual growth rate fueled by increasing allergy prevalence in the UK. Moreover, regulatory bodies have been actively collaborating with industry leaders to facilitate the development of novel therapies. Over the past few years, the UK has witnessed substantial investments into allergy immunotherapy, strengthening its position as a key market in Europe, especially with a growing demand for personalized treatment options.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 199.5(USD Million) |
| MARKET SIZE 2024 | 214.12(USD Million) |
| MARKET SIZE 2035 | 530.62(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.6% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Stallergenes Greer, Anergis, Allergy Therapeutics, Hugo Boss, Boehringer Ingelheim, Mylan, Meda Pharmaceutical, Sanofi, Hollister Incorporated, Ionis Pharmaceuticals, DBV Technologies, TheraTogs, Allergenis, Circassia, ALK Abello |
| SEGMENTS COVERED | Type, Product, Indication, Patient Type |
| KEY MARKET OPPORTUNITIES | Growing prevalence of allergies, Increased adoption of sublingual immunotherapy, Expansion of personalized medicine approaches, Enhanced patient awareness and education, Investment in digital health solutions |
| KEY MARKET DYNAMICS | Increasing prevalence of allergies, Growing awareness of immunotherapy, Technological advancements in treatments, Regulatory support and approval, Rising demand for personalized medicine |
| COUNTRIES COVERED | UK |
FAQs
What is the expected market size of the UK Allergy Immunotherapy Market in 2024?
The UK Allergy Immunotherapy Market is expected to be valued at 214.12 million USD in 2024.
What will be the projected market value of the UK Allergy Immunotherapy Market by 2035?
By 2035, the UK Allergy Immunotherapy Market is anticipated to reach a value of 530.62 million USD.
What is the expected compound annual growth rate (CAGR) for the UK Allergy Immunotherapy Market from 2025 to 2035?
The UK Allergy Immunotherapy Market is expected to grow at a CAGR of 8.6% from 2025 to 2035.
Which type of immunotherapy segment is expected to dominate the market in 2024?
In 2024, Subcutaneous Immunotherapy is expected to dominate the market with a value of 85.0 million USD.
What is the projected market value for Sublingual Immunotherapy in 2035?
The projected market value for Sublingual Immunotherapy in 2035 is estimated to be 170.0 million USD.
Who are the key players in the UK Allergy Immunotherapy Market?
Major players in the UK Allergy Immunotherapy Market include Stallergenes Greer, Anergis, and Allergy Therapeutics.
What is the expected value of Oral Immunotherapy in 2024?
In 2024, the value of Oral Immunotherapy is expected to be 59.12 million USD.
What are the projected challenges for the UK Allergy Immunotherapy Market?
Challenges facing the UK Allergy Immunotherapy Market may include regulatory hurdles and competition among key players.
How will the market size of Subcutaneous Immunotherapy change from 2024 to 2035?
The market size for Subcutaneous Immunotherapy is projected to increase significantly from 85.0 million USD in 2024 to 210.0 million USD by 2035.
What growth opportunities exist in the UK Allergy Immunotherapy Market?
Growth opportunities in the UK Allergy Immunotherapy Market include increasing awareness of allergy treatments and advancements in immunotherapy techniques.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment